These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 18786873)

  • 21. Optimizing diabetes management through glucose profiling: a case-based approach.
    Streja DA
    Prim Care Diabetes; 2008 Dec; 2(4):167-73. PubMed ID: 18786873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk.
    Aryangat AV; Gerich JE
    Vasc Health Risk Manag; 2010 Mar; 6():145-55. PubMed ID: 20448799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide.
    Kitasato L; Tojo T; Hatakeyama Y; Kameda R; Hashikata T; Yamaoka-Tojo M
    Cardiovasc Diabetol; 2012 Jun; 11():79. PubMed ID: 22748110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose lowering and cardiovascular disease: what do we know and what should we do?
    Cheng AY; Leiter LA
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S25-31. PubMed ID: 20489417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Which patients should be evaluated for blood glucose variability?
    Candido R
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():9-12. PubMed ID: 24034514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies.
    Meier M; Hummel M
    Vasc Health Risk Manag; 2009; 5():859-71. PubMed ID: 19898642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycemic risk factors of diabetic vascular complications: the role of glycemic variability.
    Zaccardi F; Pitocco D; Ghirlanda G
    Diabetes Metab Res Rev; 2009 Mar; 25(3):199-207. PubMed ID: 19172575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications.
    Sun B; Luo Z; Zhou J
    Cardiovasc Diabetol; 2021 Jan; 20(1):9. PubMed ID: 33413392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT.
    Terry T; Raravikar K; Chokrungvaranon N; Reaven PD
    Curr Cardiol Rep; 2012 Feb; 14(1):79-88. PubMed ID: 22160862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postprandial glucose regulation: new data and new implications.
    Leiter LA; Ceriello A; Davidson JA; Hanefeld M; Monnier L; Owens DR; Tajima N; Tuomilehto J;
    Clin Ther; 2005; 27 Suppl B():S42-56. PubMed ID: 16519037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postprandial hyperglycaemia--its importance and implications.
    Lüddeke HJ
    Int J Clin Pract Suppl; 1999 Jul; 104():3-7; discussion 18-20. PubMed ID: 12669731
    [No Abstract]   [Full Text] [Related]  

  • 34. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.
    Bonora E
    Int J Clin Pract Suppl; 2002 Jul; (129):5-11. PubMed ID: 12166607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood glucose control in type 2 diabetes. Basic requirements for reducing vascular complications].
    Seissler J
    Internist (Berl); 2007 Jul; 48(7):676, 678-80, 682 passim. PubMed ID: 17541528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose control in diabetes: which target level to aim for?
    Laakso M; Cederberg H
    J Intern Med; 2012 Jul; 272(1):1-12. PubMed ID: 22321169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type 2 diabetes mellitus: managing hemoglobin A(1c) and beyond.
    Fowler GC; Vasudevan DA
    South Med J; 2010 Sep; 103(9):911-6. PubMed ID: 20689486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and management of diabetes and the relationship of dglucose to kidney function.
    Mandal AK; Hiebert L
    Curr Diabetes Rev; 2015; 11(2):116-21. PubMed ID: 25732030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current strategies for controlling postprandial hyperglycaemia.
    Kunt T
    Int J Clin Pract Suppl; 2001 Sep; (123):19-23. PubMed ID: 11594292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance, pathogenesis, and management of postprandial hyperglycemia.
    Gerich JE
    Arch Intern Med; 2003 Jun; 163(11):1306-16. PubMed ID: 12796066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.